Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) appointed Dr. Helen Torley Executive Vice President and Chief Commercial Officer. Helen, who holds a Bachelor of Medicine and Bachelor of Surgery degrees (M.B. Ch.B.) from the University of Glasgow and is a Member of the Royal College of Physicians, had been Vice President and General Manager of the Bone Health Business Unit at Amgen. Read more in the prnewswire press release.
Recent Comments